RSS Feeds
Effects of Diltiazem or Lisinopril on Massive Proteinuria Associated with Diabetes Mellitus
- George L. Bakris, MD
Excerpt
Recent studies in hypertensive, diabetic rats have shown that angiotensin-converting enzyme inhibitors reduce urinary protein excretion and preserve renal function to a greater extent than other antihypertensive agents (1, 2). The effects of calcium channel antagonists on urinary protein excretion and renal hemodynamics vary (3, 4). The renal hemodynamic effects of diltiazem, however, have been shown to be similar to angiotensin-converting enzyme inhibitors (5, 6). We did a prospective crossover trial with diltiazem or lisinopril in eight diabetic, hypertensive patients with nephrotic-range proteinuria to compare the renal effects of these agents.
Patients and Methods Eight noninsulin-dependent diabetic patients (three men
This 100-word excerpt has been provided in the absence of an abstract.
Acknowledgments
Acknowledgments: The author thanks Ms. Peggy Bourque for preparing this manuscript and Dr. Sharon Anderson for her helpful comments.
Article and Author Information
-
From the Ochsner Clinic, New Orleans, Louisiana. For current author address, see end of text.
-
Grand Support: By grants from the Alton Ochsner Medical Foundation and American Diabetes Association, Louisiana Affiliate.
-
Requests for Reprints: George L. Bakris, MD, Ochsner Clinic, Section on Nephrology, 1514 Jefferson Highway, New Orleans, LA 70121.
-
Current Author Address: Dr. Bakris: Ochsner Clinic, Section on Nephrology, 1514 Jefferson Highway, New Orleans, LA 70121.
